Meet an Unreasonable Venture

Onego Bio

Disrupting the egg business

Maija Itkonen

Co-Founder & CEO at Onego Bio

More about Maija »

Connect

onego.bio

Employees 21–50

Headquarters Finland

Onego Bio produces Bioalbumen®, a bioidentical, animal-free egg protein made using precision fermentation with the patented Trichoderma reesei fungus. It offers a sustainable, scalable alternative to traditional egg protein for food manufacturers. Operating from Helsinki and San Diego, the company is pre-revenue but has strong interest from major food producers. Long term, Onego Bio aims to scale production, reduce environmental impact, and disrupt the $300 billion egg market.

Food & Water

Notable Achievements

Developed a working manufacturing process for non-animal egg protein in just two years.
Product Bioalbumen® outperforms traditional egg white powder in third-party tests.
Built a world-class team with broad experience that is not reliant on external parties.

Currently Operating in 57 Regions

Press Mentions

October 12, 2026

BREAKING: The EVERY Co prevails in legal spat with Onego Bio

A court in Delaware has dismissed a lawsuit filed by Onego Bio vs The EVERY Company, ending a protracted and ugly IP dispute.

Read on AgFunderNews »

February 4, 2026

Onego Bio Strengthens Board with Appointment of Dr. Antti Vasara

Onego Bio has enhanced its leadership by appointing Dr. Antti Vasara to its board. This strategic move reflects the company's commitment to innovation and growth within the biotechnology sector,...

Read on Voice of Alexandria »

December 9, 2025

Onego Bio Launches “The Power of Trichoderma reesei” Series to Showcase Innovation, Scale, and Real-World Applications

Onego Bio has introduced a new series showcasing the capabilities of Trichoderma reesei, highlighting the company's commitment to innovation and sustainable biotechnology. This launch underscores...

September 23, 2025

Agronomics Limited Announces Onego Bio Update

Onego Bio has achieved a significant milestone by receiving FDA approval to commercialize its innovative egg protein, Bioalbumen. This approval highlights Onego Bio's commitment to sustainable...

Read on FinanzNachrichten.de »

September 22, 2025

Onego Bio receives approval from FDA to begin commercializing egg protein

Onego Bio has received FDA approval to commercialize its innovative egg protein derived from fermentation. This advancement signifies a breakthrough in sustainable food production, positioning...

Read on BizTimes - Milwaukee Business News »

March 28, 2025

Finnish food tech company Onego Bio to invest up to $300 million to build flagship plant in Jefferson

Onego Bio, a biotechnology company based in Jefferson, Wisconsin, is making significant strides in sustainable protein production through fermentation. Their innovative facility aims to...

Read on BizTimes - Milwaukee Business News »